All News

A new test could reliably detect early increases in PSA levels in men who have undergone prostate cancer surgery.

Ethicon, Inc., recently announced the availability of the Gynecare TVT Exact Continence System, a minimally invasive retropubic sling used in an outpatient setting for the treatment of stress urinary incontinence.

Patients with the most aggressive forms of prostate cancer who had radical prostatectomy procedures had a 10-year cancer-specific survival rate of 92% and an overall survival rate of 77%, researchers from two institutions recently reported.

The AUA has announced its support of H.R. 6389 (the Prostate Act), which, if passed, would require coordination and intensification of prostate cancer research by government departments.

Opposition to federal health reform approved by Congress and President Obama in March 2010 continues to find legal recognition in the states.

Urology Times wanted to learn more about urologists' current use of nonphysician providers and whether these providers' numbers and responsibilities are expanding, especially given growing concerns about a work force shortage in urology.

Novel dual energy multi-detector computed tomography (DECT) image processing software can accurately characterize urinary calculi composition.

Regarding the article, "Group challenges RT self-referral charges" (August 2010): Dr. Kapoor questions real data regarding self-referral concerns in in-office ancillary services (IOAS) arrangements for IMRT. Yet he states that a lot of patients will be adversely affected by legislation without citing any statistical data to back up this statement since it's impossible to measure the effect of something that has yet to occur.

It is easy to have a vast knowledge of coding and billing but at the same time misunderstand or misinterpret the application of a particular rule.

Early results from the first multicenter trial of stereotactic robotic radiosurgery are in, with researchers reporting that toxicity is acceptable and PSA responses are favorable.

Peter Bretan, MD, a urologist in private practice in Novato, CA, is the sole urologist for a company specializing in telemedicine-in this case, the use of robots to connect with computers at great distance from the bedside of the patient.

In the treatment of benign prostatic obstruction, bipolar and monopolar transurethral resection of the prostate yield comparable outcomes at 12 months.

An experimental new device may help clinicians in the surgical treatment of lower pole stones by using ultrasound to move stones through the kidney collecting system.

An investigational metered dose, aerosolized spray containing a mixture of lidocaine and prilocaine (PSD502) is an effective treatment for premature ejaculation in both circumcised and uncircumcised men, although the magnitude of response is relatively greater in uncircumcised men.

A new premature ejaculation therapy is simple to apply, is truly an on-demand therapy that takes effect in less than 5 minutes, prolongs intravaginal ejaculatory latency in the range of five fold, and does not seem to reduce sensitivity.

As the capital markets have improved, more investors have shifted their concern from weathering the financial crisis to anticipating the inflationary effects of rising federal spending and debt.

Authors from two recent studies discuss the risks men face in undergoing biopsy as well as the steps urologists are taking to minimize these risks.

As employers (and individuals) select health insurance plans with higher deductibles that place more financial responsibility on the patient, it's more important than ever that medical practices revamp front office collection procedures and place more responsibility on the front office staff.

Within the next year or so, depending on how quickly the FDA acts, the U.S. may be getting its first therapeutic agent specifically indicated for the treatment of premature ejaculation.

Urologists share a diverse range of lessons they've learned since they started practicing.

A novel minimally invasive system for the treatment of lower urinary tract symptoms due to BPH appears to be safe and efficacious for as long as 2 years after the procedure is performed.

A nanotechnology PSA assay shows potential for identifying prostate cancer patients at increased risk of recurrence after radical prostatectomy.

A novel experimental technology for removing kidney stone fragments using magnetic energy has passed a pair of early tests.

Urodynamic results do correlate with treatment outcomes in idiopathic overactive bladder treatment, at least with onabotulinumtoxin A (Botox). Surprisingly, despite all the urodynamic studies done in OAB, this is new information.

Multi-parametric magnetic resonance imaging (MP-MRI) in patients with intermediate or advanced prostate cancer offers additional information sufficient enough to allow surgeons to alter management plans to the benefit of the patient.

Although inflammation in deceased donor kidneys represent an increased risk in acute transplant failures, there is no causal connection, Austrian researchers say.

Less than 1 month remains for physicians to file a claim for the $350 million settlement reached against UnitedHealth Group and its Ingenix subsidiary for its flawed out-of-network reimbursement database.